Back to mobile site

JPMorgan Starts Telix Pharmaceuticals Ltd (TLX:AU) (TLX) at Overweight

June 1, 2026 12:55 AM EDT Send to a Friend
JPMorgan analyst Chris Cooper initiates coverage on Telix Pharmaceuticals Ltd (TLX:AU) (NASDAQ: TLX) with a Overweight rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login